These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1781476)

  • 41. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 42. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

  • 43. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
    Hassan E; Leslie J; Martir-Herrero ML
    Am J Hosp Pharm; 1994 Sep; 51(17):2143-5. PubMed ID: 7985689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comments: i.v. drug compatibility.
    Drug Intell Clin Pharm; 1986 Sep; 20(9):714-5. PubMed ID: 3757789
    [No Abstract]   [Full Text] [Related]  

  • 45. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 46. Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection.
    Percy LA; Rho JP
    Am J Hosp Pharm; 1993 Apr; 50(4):715-6. PubMed ID: 8470693
    [No Abstract]   [Full Text] [Related]  

  • 47. Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
    Benedict MK; Roche VF; Banakar UV; Hilleman DE
    Am J Hosp Pharm; 1988 May; 45(5):1117-8. PubMed ID: 3400656
    [No Abstract]   [Full Text] [Related]  

  • 48. Visual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injection.
    Outman WR; Mitrano FP; Baptista RJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1538-9. PubMed ID: 1909095
    [No Abstract]   [Full Text] [Related]  

  • 49. Visual compatibility of nalbuphine hydrochloride and promethazine hydrochloride.
    Jimenez MD
    Am J Hosp Pharm; 1988 Jun; 45(6):1278. PubMed ID: 3414694
    [No Abstract]   [Full Text] [Related]  

  • 50. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
    Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ
    Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033
    [No Abstract]   [Full Text] [Related]  

  • 51. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
    Hutchings SR; Rusho WJ; Tyler LS
    Am J Health Syst Pharm; 1996 Sep; 53(18):2185-8. PubMed ID: 8879326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
    Cummings DS; Park MK; Howard AB
    Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual compatibility of narcotic analgesics with selected intravenous admixtures.
    Smythe MA; Patel MA; Gasloli RA
    Am J Hosp Pharm; 1990 Apr; 47(4):819-20. PubMed ID: 1969712
    [No Abstract]   [Full Text] [Related]  

  • 54. Compatibility of verapamil hydrochloride injection with commonly used additives.
    Cutie MR
    Am J Hosp Pharm; 1983 Jul; 40(7):1205-7. PubMed ID: 6881161
    [No Abstract]   [Full Text] [Related]  

  • 55. Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
    Zanetti LA
    Am J Hosp Pharm; 1992 Aug; 49(8):1911. PubMed ID: 1442831
    [No Abstract]   [Full Text] [Related]  

  • 56. Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
    Sprandel KA; Styrczula DE; Deyo K; Sibley C; Rodvold KA
    Am J Health Syst Pharm; 2005 Jan; 62(1):88-92. PubMed ID: 15658079
    [No Abstract]   [Full Text] [Related]  

  • 57. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
    Gayed AA; Keshary PR; Hinkle RL
    Am J Health Syst Pharm; 1995 Mar; 52(5):516-20. PubMed ID: 7606558
    [No Abstract]   [Full Text] [Related]  

  • 58. Visual compatibility of hydroxyzine hydrochloride with various antineoplastic agents.
    Marquardt ED
    Am J Hosp Pharm; 1988 Oct; 45(10):2127. PubMed ID: 3228084
    [No Abstract]   [Full Text] [Related]  

  • 59. Visual compatibility of midazolam hydrochloride with common preoperative injectable medications.
    Forman JK; Souney PF
    Am J Hosp Pharm; 1987 Oct; 44(10):2298-9. PubMed ID: 3687973
    [No Abstract]   [Full Text] [Related]  

  • 60. Visual compatibility of clonidine with selected drugs.
    Veggeland T
    Am J Health Syst Pharm; 2005 Oct; 62(19):1968-9. PubMed ID: 16174826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.